Institutional investors purchased a net $6.0 million shares of IMMU during the quarter ended December 2017, and now own 71.87% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MILLENNIUM MANAGEMENT LLC Bought 3.4 Million shares of Immunomedics Inc
CITADEL ADVISORS LLC Bought 3.3 Million shares of Immunomedics Inc
PALO ALTO INVESTORS LLC Bought 1.8 Million shares of Immunomedics Inc